Capricor Therapeutics

1 follower


Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Industries

Headquarters

Employees

Links

Org chart

Linda Marbán
Chief Executive Officer

Linda Marbán

Collapse
Aj Bergmann
Chief Financial Officer
Kristi A. H. Elliott
Chief Science Officer
Mark Awadalla
Vice President Clinical Research & Development Operations
Yushi Feng
VP of Regulatory Affairs
Jonathan Tayco
Vice President Of Program Management, Operations And Quality
Joe Z.
Senior IP Counsel